Back to search
FDAFDA · Food and drugs·Recall number D-0294-2015

Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only, 25 units per box/50 units per case, Hospira Inc., Lake Forest, IL --- NDC 0409-9094-61

Published December 17, 2014 · Recall initiated: December 3, 2014

Summary

FDA records drug Class II recall D-0294-2015, published December 17, 2014 and initiated December 3, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 62,650 vials; Lot: Lot 41-099-DK, exp 01MAY2016, NDC 0409-9094-61. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; improperly crimped fliptop vials

What to do

Voluntary: Firm initiated · Letter

Get an email if FENTANYL CITRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FENTANYL CITRATE
Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 41-099-DK, exp 01MAY2016, NDC 0409-9094-61
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only, 25 units per box/50 units per case, Hospira Inc., Lake Forest, IL --- NDC 0409-9094-61 recalled?

Yes. FDA published recall D-0294-2015 on December 17, 2014. Reported hazard: Lack of Assurance of Sterility; improperly crimped fliptop vials

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FENTANYL CITRATE.